Health | Page 1222 of 1374 | SpiritIndia.com

Diabetes :: Exubera – Inhaled Insulin Combination for Treatment of Diabetes

There is a new, potential alternative for many of the more than 5 million Americans who take insulin injections, with the Food and Drug Administration’s approval today of the first ever inhaled insulin. Exubera, an inhaled powder form of recombinant human insulin (rDNA) for the treatment of adult patients with type 1 and type 2 diabetes, is the first new insulin delivery option introduced since the discovery of insulin in the 1920s.

Diabetes :: Weight Loss Improves Bladder Control in Women with Prediabetes

Losing a modest amount of weight through dietary changes and increased physical activity reduces the occurrence of urinary incontinence (UI) in women with prediabetes, a condition in which blood glucose levels are higher than normal but not yet diabetic. This finding comes from a new study, published in the February issue of Diabetes Care, of women who participated in the Diabetes Prevention Program (DPP), a landmark clinical study funded by the National Institutes of Health (NIH).

Osteoporosis :: Information about Osteoporosis

Millions of older Americans suffer from osteoporosis, a disease that thins and weakens bones to the point that they become fragile and break easily. Osteoporosis is especially common in older women.

Depression :: Team approach to treat depression in elderly people

A “team approach” to treat depression in elderly people produces effective, lasting results, a new U.S. study finds.

Cancer :: Sutent, sunitinib for Gastrointestinal – Stomach Cancer, Kidney Cancer

The Food and Drug Administration (FDA) announced approval of Sutent (sunitinib), a new targeted anti-cancer treatment for patients with gastrointestinal stromal tumors (GIST), a rare stomach cancer, and advanced kidney cancer. This action marks the first time the agency has approved a new oncology product for two indications simultaneously.

Health :: Nature Suggests a Promising Strategy for Artificial Bone

Researchers supported by the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, report they have harnessed the unique physics of sea water as it freezes to guide the production of what could be a new generation of more biocompatible materials for artificial bone.

Alzheimer’s Disease :: Alzheimer’s disease links to abnormal cell division

A new study in mice suggests that Alzheimer’s disease (AD) may be triggered when adult neurons try to divide. The finding helps researchers understand what goes wrong in the disease and may lead to new ways of treating it.

SIDS :: SIDS increases in the cold winter

The number of infants who die from Sudden Infant Death Syndrome, or SIDS, increases in the cold winter months, according to the National Institute of Child Health and Human Development (NICHD), one of the National Institutes of Health. During these colder months, parents often place extra blankets or clothes on infants, hoping to provide them with more warmth. In fact, the extra material may actually increase infants’ risk for SIDS.

Eczema :: Updated labeling for eczema drugs, Elidel and Protopic

There is an approval of updated labeling for two topical eczema drugs, Elidel Cream (pimecrolimus) and Protopic Ointment (tacrolimus).

Influenza :: Fraudulent, unapproved influenza related products

FDA considers the sale of unlicensed or unapproved influenza – related products as a potentially significant threat to the public health and is taking measures to protect consumers from fraudulent products that claim to prevent or treat seasonal or avian (bird) influenza in people.